Several factors contribute to these elevated costs: Patent protection Most GLP-1 medications are still under patent, preventing generic competition Manufacturing complexity These are biologic medications that require specialized production processes Research and development costs Pharmaceutical companies invest heavily in clinical trials and regulatory approval Market positioning These medications are often priced as premium treatments Without insurance coverage, patients face the full retail price, which can make these medications financially inaccessible for many people who need them
This shift has turned GLP-1 therapy into one of the fastest-growing pharmaceutical categories in the world
Or try The Laser Focus Pill, which packs 10 mg of THCV with supportive CBG and CBDA for a clear, grounded boost
USA 103 , 23342339 (2006)
Blood pressure should be stable before donation
Document any new, worsening, or severe side effects after switching from Zepbound to Wegovy
